Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioXcel Therapeutics Inc (F: BX2)

 
BX2 Technical Analysis
2
As on 18th Feb 2025 BX2 STOCK Price closed @ 2.56 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.52 & Strong Sell for SHORT-TERM with Stoploss of 3.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BX2STOCK Price

Open 2.56 Change Price %
High 2.56 1 Day 2.40 1500.00
Low 2.56 1 Week 2.26 753.33
Close 2.56 1 Month 2.28 814.29
Volume N/A 1 Year -1.00 -28.09
52 Week High 4.78 | 52 Week Low 0.23
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
BX2 2.56 1500.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
BX2
Daily Charts		 BX2
Intraday Charts		 Whats New @
Bazaartrend		 BX2
Free Analysis
 
BX2 Important Levels Intraday
RESISTANCE2.56
RESISTANCE2.56
RESISTANCE2.56
RESISTANCE2.56
RESISTANCE2.56
RESISTANCE2.56
RESISTANCE2.56
RESISTANCE2.56
 
BX2 Forecast February 2025
Share
4th UP Forecast7.42
3rd UP Forecast5.86
2nd UP Forecast4.9
1st UP Forecast3.93
1st DOWN Forecast1.19
2nd DOWN Forecast0.22
3rd DOWN Forecast-0.74
4th DOWN Forecast-2.3
 
BX2 Weekly Forecast
4th UP Forecast3.58
3rd UP Forecast3.25
2nd UP Forecast3.05
1st UP Forecast2.85
1st DOWN Forecast2.27
2nd DOWN Forecast2.07
3rd DOWN Forecast1.87
4th DOWN Forecast1.54
 
BX2 Forecast2025
4th UP Forecast11.71
3rd UP Forecast8.78
2nd UP Forecast6.96
1st UP Forecast5.15
1st DOWN Forecast-0.03
2nd DOWN Forecast-1.84
3rd DOWN Forecast-3.66
4th DOWN Forecast-6.59
 
 
BX2 Other Details
Segment EQ
Market Capital 729804992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BX2 Address
BX2
 
BX2 Latest News
 
Your Comments and Response on BioXcel Therapeutics Inc
 
BX2 Business Profile
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic receptor agonist dexmedetomidine for the treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immune activator for the treatment of prostate and pancreatic cancers, and solid tumors. BioXcel Therapeutics, Inc. has a collaboration with collaboration with the VA Connecticut Healthcare System and the Yale University Medical School for patients suffering from post-traumatic stress disorder related to alcohol and substance abuse disorder. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut. Address: 555 Long Wharf Drive, New Haven, CT, United States, 06511
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service